Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Sales (2018 - 2025)

AVITA Medical filings provide 8 years of Return on Sales readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales rose 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for AVITA Medical, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.03% in Q4 2023 to a low of 0.02% in Q1 2024.
  • Median Return on Sales over the past 5 years was 0.01% (2021), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Sales: grew 3bps in 2021 and later decreased -3bps in 2024.
  • AVITA Medical's Return on Sales stood at 0.01% in 2021, then skyrocketed by 31bps to 0.01% in 2022, then skyrocketed by 557bps to 0.03% in 2023, then plummeted by -124bps to 0.01% in 2024, then soared by 80bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.